Employers drop obesity drug coverage as cash-pay programs grow
When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop…
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
UnitedHealth Group releases results of independent audit
UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans |…
Pharma’s ‘Dr. Optimistic’ is worried about the industry’s future
In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview me about…
Meta urged by state AGs to regulate weight loss drug ads
More than three dozen state attorneys general are urging Meta to better enforce its policies to thwart a…
Eli Lilly obesity pill maintains weight loss after Wegovy, ZepboundÂ
Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight…
Mutual mistrust: FDA staff wary as Høeg becomes top drug regulator
WASHINGTON — In 2008, Tracy Beth Høeg, then a resident physician and ultramarathon runner, expressed dismay at vice…
Eli Lilly to build $6 billion Alabama manufacturing plant
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept.…
Health insurer prescription costs rise 20%, GLP-1s cited as cause
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
RFK Jr.’s vaccine panel to vote on hepatitis B shot for babies
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. looks on as he attends a press…
FDA removes Office of Nonprescription Drugs Director Theresa Michele
WASHINGTON — The Food and Drug Administration removed the longtime director of the office of over-the-counter drugs from…